Donor T cells lacking fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients

Transplantation

Volumn 77, Issue 6, 2004, Pages 804-812

  Marks, Lianne ^a   Altman, Norman H ^a   Podack, Eckhard R ^a   Levy, Robert B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; MINOR HISTOCOMPATIBILITY ANTIGEN; PERFORIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW HYPOPLASIA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; MONONUCLEAR CELL; MORTALITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; WEIGHT REDUCTION;

ANIMALS; BASE SEQUENCE; BONE MARROW TRANSPLANTATION; CROSS-LINKING REAGENTS; DNA PRIMERS; FAS LIGAND PROTEIN; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; IMMUNOPHENOTYPING; LYMPHOCYTE TRANSFUSION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MINOR HISTOCOMPATIBILITY ANTIGENS; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 1642529828     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000110416.96307.D5     Document Type: Article

References (35)

1. Marmont AM, Gale RP, Butturini A, et al. T-cell depletion in allogeneic bone marrow transplantation: progress and problems. Haematologica 1989; 74: 235.
2. Korngold R, Wettstein PJ. Immunodominance in the graft-vs-host disease T cell response to minor histocompatibility antigens. J Immunol 1990; 145: 4079.
3. Baker MB, Altman NH, Podack ER, et al. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J Exp Med 1996; 183: 2645.
4. Graubert TA, DiPersio JF, Russell JH, et al. Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. J Clin Invest 1997; 100: 904.
5. Miwa K, Hashimoto H, Yatomi T, et al. Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease. Int Immunol 1999; 11: 925.
6. Jiang Z, Podack E, Levy RB. Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4(+) donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease pathogenesis. Blood 2001; 98: 390.
7. Brochu S, Rioux-Masse B, Roy J, et al. Massive activation-induced cell death of alloreactive T cells with apoptosis of bystander postthymic T cells prevents immune reconstitution in mice with graft-versus-host disease. Blood 1999; 94: 390.
8. Wekerle T, Kurtz J, Sayegh MH, et al. Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death. J Immunol 2001; 166: 2311.
9. + T cells can mediate resistance preventing allogeneic marrow engraftment in the simultaneous absence of perforin, CD95L, TNFR1 and TRAIL. Blood 2003. In press.
10. Spielman J, Lee RK, Podack ER. Perforin/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis. J Immunol 1998; 161: 7063.
11. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324: 667.
12. Ferrara JL, Levy R, Chao NJ. Pathophysiologic mechanisms of acute graft-vs.-host disease. Biol Blood Marrow Transplant 1999; 5: 347.
13. Berger M, Wettstein PJ, Korngold R. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens. Transplantation 1994; 57: 1095.
14. Thiele DL, Charley MR, Calomeni JA, et al. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells. J Immunol 1987; 138: 51.
15. Graubert TA, Russell JH, Ley TJ. The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection. Blood 1996; 87: 1232.
16. Blazar BR, Taylor PA, Vallera DA. CD4+ and CD8+ T cells each can utilize a perforin-dependent pathway to mediate lethal graft-versus-host disease in major histocompatibility complex-disparate recipients. Transplantation 1997; 64: 571.
17. Hattori K, Hirano T, Miyajima H, et al. Differential effects of anti-Fas ligand and anti-tumor necrosis factor alpha antibodies on acute graft-versus-host disease pathologies. Blood 1998; 91: 4051.
18. Hsieh MH, Varadi G, Flomenberg N, et al. Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk. Biol Blood Marrow Transplant 2002; 8: 303.
19. Braun MY, Lowin B, French L, et al. Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med 1996; 183: 657.
20. Martin PJ, Akatsuka Y, Hahne M, et al. Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection. Blood 1998; 92: 2177.
21. Schmaltz C, Alpdogan O, Horndasch KJ, et al. Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect. Blood 2001; 97: 2886.
22. Kondo T, Suda T, Fukuyama H, et al. Essential roles of the Fas ligand in the development of hepatitis. Nat Med 1997; 3: 409.
23. Kennedy NJ, Russell JQ, Michail N, et al. Liver damage by infiltrating CD8(+) T cells is Fas dependent. J Immunol 2001; 167: 6654.
24. Nakamoto Y, Guidotti LG, Pasquetto V, et al. Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice. J Immunol 1997; 158: 5692.
25. Wettstein PJ. Immunodominance in the T-Cell response to multiple non-H-2 histocomptability antigens. II. Observation of a hierarchy among dominant antigens. Immunogenetics 1986; 24: 24.
26. Torok-Storb B, Holmberg L. Role of marrow microenvironment in engraftment and maintenance of allogeneic hematopoietic stem cells. Bone Marrow Transplant 1994; 14(Suppl 4): S71.
27. Ferrara JL. Paradigm shift for graft-versus-host disease. Bone Marrow Transplant 1994; 14: 183.
28. Badovinac VP, Tvinnereim AR, Harty JT. Regulation of antigen-specific CD8(+) T cell homeostasis by perforin and interferon-gamma. Science 2000; 290: 1354.
29. Kaech SM, Ahmed R. Memory CD8(+) T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat Immunol 2001; 2: 415.
30. Gleichmann E, Pals ST, Rolink AG, et al. Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. Immunol Today 1984; 5: 324.
31. Tschetter JR, Mozes E, Shearer GM. Progression from acute to chronic disease in a murine parent-into-F(1) model of graft-versus-host disease. J Immunol 2000; 165: 5987.
32. Gorak-Stolinska P, Truman JP, Kemeny DM, et al. Activation-induced cell death of human T-cell subsets is mediated by Fas and granzyme B but is independent of TNF-alpha. J Leukoc Biol 2001; 70: 756.
33. Binder D, van den Broek MF, Kagi D, et al. Aplastic anemia rescued by exhaustion of cytokine-secreting CD8(+) T cells in persistent infection with lymphocytic choriomeningitis virus. J Exp Med 1998; 187: 1903.
34. Matloubian M, Suresh M, Glass A, et al. A role for perforin in downregulating T-cell responses during chronic viral infection. J Virol 1999; 73: 2527.
35. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familiar hemophagocytic: lymphohistiocytosis. Science 1999; 286: 1957.